155 related articles for article (PubMed ID: 37697023)
1. Diversity-oriented synthesis of 1H-1,2,3-triazole tethered pyrazolo[5,1-b]quinazoline hybrids as antimicrobial agents.
Chudasama DD; Patel MS; Parekh JN; Patel HC; Ram KR
Mol Divers; 2023 Sep; ():. PubMed ID: 37697023
[TBL] [Abstract][Full Text] [Related]
2. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
Abdallah AEM; Elgemeie GH
Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
4. Efficient click chemistry towards novel 1H-1,2,3-triazole-tethered 4H-chromene-d-glucose conjugates: Design, synthesis and evaluation of in vitro antibacterial, MRSA and antifungal activities.
Thanh ND; Hai DS; Ngoc Bich VT; Thu Hien PT; Ky Duyen NT; Mai NT; Dung TT; Toan VN; Kim Van HT; Dang LH; Toan DN; Thanh Van TT
Eur J Med Chem; 2019 Apr; 167():454-471. PubMed ID: 30784879
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents.
Al-Blewi FF; Almehmadi MA; Aouad MR; Bardaweel SK; Sahu PK; Messali M; Rezki N; El Ashry ESH
Chem Cent J; 2018 Nov; 12(1):110. PubMed ID: 30387018
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Activity of Synthesized 2-Methylthiobenzo[g][1,2,4]- triazolo[1,5-a]quinazoline Derivatives.
Al-Salahi R; Abuelizz HA; Wadi M; El Dib RA; Alotaibi MA; Marzouk M
Med Chem; 2016; 12(8):760-766. PubMed ID: 27140181
[TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic Poly(aniline-co-m-phenylenediamine)@Fe
Nezhad SM; Pourmousavi SA; Zare EN
Curr Org Synth; 2022 Mar; 19(2):246-266. PubMed ID: 34736384
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new thiazolyl-pyrazolyl-1,2,3-triazole derivatives as potential antimicrobial agents.
Nalawade J; Shinde A; Chavan A; Patil S; Suryavanshi M; Modak M; Choudhari P; Bobade VD; Mhaske PC
Eur J Med Chem; 2019 Oct; 179():649-659. PubMed ID: 31279297
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity profile of novel triazole/quinoline hybrids.
Jamshidi H; Naimi-Jamal MR; Safavi M; RayatSanati K; Azerang P; Tahghighi A
Chem Biol Drug Des; 2022 Dec; 100(6):935-946. PubMed ID: 35147277
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Quinazoline-2,4(1
Boshta NM; El-Essawy FA; Alshammari MB; Noreldein SG; Darwesh OM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744976
[TBL] [Abstract][Full Text] [Related]
11. Oxazolone-1,2,3-Triazole Hybrids: Design, Synthesis and Antimicrobial Evaluation.
Lal K; Kumar L; Kumar A; Kumar A
Curr Top Med Chem; 2018; 18(17):1506-1513. PubMed ID: 30210002
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents.
Emmadi NR; Bingi C; Kotapalli SS; Ummanni R; Nanubolu JB; Atmakur K
Bioorg Med Chem Lett; 2015 Aug; 25(15):2918-22. PubMed ID: 26048808
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis, biological evaluation of bis-(1,2,3- and 1,2,4)-triazole derivatives as potential antimicrobial and antifungal agents.
Bitla S; Gayatri AA; Puchakayala MR; Kumar Bhukya V; Vannada J; Dhanavath R; Kuthati B; Kothula D; Sagurthi SR; Atcha KR
Bioorg Med Chem Lett; 2021 Jun; 41():128004. PubMed ID: 33811989
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of newly synthesized methylsulfanyl-triazoloquinazoline derivatives.
Al-Salahi R; Marzouk M; Awad G; Al-Omar M; Ezzeldin E
J Pharm Pharmacol; 2013 Jun; 65(6):790-7. PubMed ID: 23647672
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial and cytotoxic activities of isoniazid connected menthone derivatives and their investigation of clinical pathogens causing infectious disease.
Al-Khattaf FS; Mani A; Atef Hatamleh A; Akbar I
J Infect Public Health; 2021 Apr; 14(4):533-542. PubMed ID: 33744741
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, characterization, antimicrobial evaluation and molecular modeling studies of some dehydroacetic acid-chalcone-1,2,3-triazole hybrids.
Lal K; Yadav P; Kumar A; Kumar A; Paul AK
Bioorg Chem; 2018 Apr; 77():236-244. PubMed ID: 29421698
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antibacterial and antifungal activities of novel 1,2,4-triazolium derivatives.
Luo Y; Lu YH; Gan LL; Zhou CH; Wu J; Geng RX; Zhang YY
Arch Pharm (Weinheim); 2009 Jul; 342(7):386-93. PubMed ID: 19544478
[TBL] [Abstract][Full Text] [Related]
18. Urea-thiazole/benzothiazole hybrids with a triazole linker: synthesis, antimicrobial potential, pharmacokinetic profile and in silico mechanistic studies.
Poonia N; Lal K; Kumar A; Kumar A; Sahu S; Baidya ATK; Kumar R
Mol Divers; 2022 Oct; 26(5):2375-2391. PubMed ID: 34671895
[TBL] [Abstract][Full Text] [Related]
19. Cu-Al mixed oxide-catalysed multi-component synthesis of gluco- and allofuranose-linked 1,2,3-triazole derivatives.
Corona-Sánchez R; Sánchez-Eleuterio A; Negrón-Lomas C; Ruiz Almazan Y; Lomas-Romero L; Negrón-Silva GE; Rodríguez-Sánchez ÁC
R Soc Open Sci; 2020 Jul; 7(7):200290. PubMed ID: 32874626
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel 2H-chromen-2-one derivatives bearing 1,2,3-triazole moiety as lead antimicrobials.
Kushwaha K; Kaushik N; Lata ; Jain SC
Bioorg Med Chem Lett; 2014 Apr; 24(7):1795-801. PubMed ID: 24594353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
